Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - benzoylis peroxidum, clindamycinum - gel - benzoylis peroxidum 50 mg a benzoylis peroxidum con acqua, clindamycinum 10 mg a clindamycini phosphas, excipiens annuncio gelatum pro 1 g. - akne vulgaris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - clindamycinum, tretinoinum - gel - clindamycini phosphas 12.0 mg corresp. clindamycinum 10.0 mg, tretinoinum 0.25 mg, acidum citricum, dinatrii edetas, polysorbatum 80, trometamolum, carbomerum 981, glycerolum, e 321 0.2 mg, propylis parahydroxybenzoas 0.3 mg, e 218 1.5 mg, aqua purificata q.s. ad gelatum pro 1 g. - trattamento topico dell'acne vulgaris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulato per la realizzazione di una soluzione orale - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulato per la realizzazione di una soluzione orale - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - capsule rigide - clindamycinum 150 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 224.13 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - capsule rigide - clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - soluzione iniettabile - clindamycinum 300 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum q.s. ad ph, alcohol benzylicus 18 mg, aqua ad iniectabile ad solutionem pro 2 ml corresp. natrium 17.92 mg. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - soluzione iniettabile - clindamycinum 600 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum q.s. ad ph, alcohol benzylicus 36 mg, aqua ad iniectabile ad solutionem pro 4 ml corresp. natrium 35.84 mg. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - clindamycinum - capsule - clindamycinum 150 mg ut clindamycini hydrochloridum, amylum pregelificatum, talcum, magnesii stearas, lactosum monohydricum 78.8 mg, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - clindamycinum - capsule - clindamycinum 300 mg ut clindamycini hydrochloridum, amylum pregelificatum, talcum, magnesii stearas, lactosum monohydricum 147.67 mg, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula. - malattie infettive - synthetika